the cannome™ PureForm is developing the complete CANNOME™, our trademarked description of the entire suite of cannabinoids. The first member of the CANNOME™ family is PureForm CBD. Now, using the same natural sources we used for creating PureForm CBD, the company is at work building more than 10 of the 140 cannabinoids. The ultimate therapeutic potential of compounds in the CANNOME™ is untapped, because before PureForm Global developed its manufacturing technology, these cannabinoids were unavailable in sufficient quantities to enable research. We continue our work with the scientific community in order to determine which compounds show the most therapeutic potential. The most promising cannabinoids are the first subjects for our Cyclic Terpene Assembly technology.